The drug that produces greater total weight loss will also produce greater absolute lean mass loss
GLP-1 stands for Glucagon-Like Peptide-1
In this study, 72 patients were enrolled and were randomly assigned to one of five ascending dose cohorts of subcutaneous LY, a placebo, or dulaglutide 1.5mg
However, patients should be advised to report symptoms suggestive of liver injury, including: Persistent nausea or vomiting unrelated to expected GI side effects Right upper quadrant abdominal pain (which may also indicate gallbladder disease, a known risk with GLP-1 therapy) Jaundice (yellowing of skin or eyes) Dark urine or pale stools Unexplained fatigue or malaise Clinicians should maintain a low threshold for investigating these symptoms with comprehensive liver function tests, including ALT, AST, alkaline phosphatase, bilirubin, albumin, and INR/prothrombin time
Faster Results: With instant absorption, IV therapy offers quicker and more noticeable improvements in skin tone
Fatigue and its management in the workplace